Middle East and Africa Carbapenem-Based Antibiotics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Meropenem, Doripenem, Imipenem, Tebipenem, and Others), Indication (Bacterial Meningitis, Acute Pelvic Infections, Respiratory Tract Infections, Intra-Abdominal Infections, Urinary Tract Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies)

No. of Pages: 116    |    Report Code: TIPRE00028814    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East and Africa Carbapenem-Based Antibiotics Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Middle East and Africa Carbapenem-based Antibiotics Market – By Type

1.3.2        Middle East and Africa Carbapenem-based Antibiotics Market – By Indication

1.3.3        Middle East and Africa Carbapenem-based Antibiotics Market – By Distribution Channel

1.3.4        Middle East and Africa Carbapenem-based Antibiotics Market – By Country

2.           Carbapenem-based Antibiotics Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Middle East and Africa Carbapenem-based Antibiotics Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Middle East and Africa– PEST Analysis

4.3         Expert Opinions

5.           Carbapenem-based Antibiotics Market – Key Market Dynamics

5.1         Drivers

5.1.1        Rising Prevalence of Gram-Negative Bacterial Infections

5.1.2        Increasing Production of Generic Drugs

5.2         Market Restraints

5.2.1        Tedious and Expensive Process of Antibiotic Development

5.3         Market Opportunities

5.3.1        Private and Public Partnerships

5.4         Future Trends

5.4.1        Strategic Advancement for New Antibiotic Identification

5.5         Impact Analysis

6.           Carbapenem-based Antibiotics Market – Middle East and Africa Analysis

6.1         Middle East and Africa Carbapenem-based Antibiotics Market Revenue Forecast and Analysis

7.           Carbapenem-based Antibiotics Market Analysis – By Type

7.1         Overview

7.2         Carbapenem-based Antibiotics Market Revenue Share, by Type (2021 and 2028)

7.3         Meropenem

7.3.1        Overview

7.3.2        Meropenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Doripenem

7.4.1        Overview

7.4.2        Doripenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Imipenem

7.5.1        Overview

7.5.2        Imipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.6         Tebipenem

7.6.1        Overview

7.6.2        Tebipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.7         Others

7.7.1        Overview

7.7.2        Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.           Carbapenem-based Antibiotics Market – By Indication

8.1         Overview

8.2         Carbapenem-based Antibiotics Market, by Indication, 2021 and 2028 (%)

8.3         Bacterial Meningitis

8.3.1        Overview

8.3.2        Bacterial Meningitis: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Acute Pelvic Infections

8.4.1        Overview

8.4.2        Acute Pelvic Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Respiratory Tract Infections

8.5.1        Overview

8.5.2        Respiratory Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Intra-abdominal Infections

8.6.1        Overview

8.6.2        Intra-abdominal Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.7         Urinary Tract Infections

8.7.1        Overview

8.7.2        Urinary Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.8         Others

8.8.1        Overview

8.8.2        Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

9.           Carbapenem-based Antibiotics Market – By Distribution Channel

9.1         Overview

9.2         Carbapenem-based Antibiotics Market, by Distribution Channel, 2021 and 2028 (%)

9.3         Retail Pharmacies

9.3.1        Overview

9.3.2        Retail Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Online Pharmacies

9.4.1        Overview

9.4.2        Online Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Hospital Pharmacies

9.5.1        Overview

9.5.2        Hospital Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

10.        Carbapenem-based Antibiotics Market –Country Analysis

10.1      Middle East and Africa: Carbapenem-based Antibiotics Market

10.1.1     Overview

10.1.2     Middle East and Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.3     Middle East and Africa: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.4     Middle East and Africa: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ Million)

10.1.5     Middle East and Africa: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ Million)

10.1.6     Middle East and Africa: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)

10.1.6.1       UAE: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.1.1       UAE: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.1.2       UAE: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.6.1.3       UAE: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.1.6.1.4       UAE: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.1.6.2       Saudi Arabia: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.2.1       Saudi Arabia: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.2.2       Saudi Arabia: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.6.2.3       Saudi Arabia: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.1.6.2.4       Saudi Arabia: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.1.6.3       South Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.3.1       South Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.3.2       South Africa: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.6.3.3       South Africa: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.1.6.3.4       South Africa: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.1.6.4       Rest of Middle East and Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.4.1       Rest of Middle East and Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.4.2       Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.6.4.3       Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.1.6.4.4       Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

11.        Carbapenem-based Antibiotics Market–Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        COMPANY PROFILES

12.1      ACS Dobfar S.p.A

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Gland Pharma Limited

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Merck & Co., Inc.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Savior Lifetec

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Pfizer Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Spero Therapeutics

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             Middle East and Africa: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 2.             Middle East and Africa: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 3.             Middle East and Africa: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 4.             UAE: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 5.             UAE: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 6.             UAE: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 7.             Saudi Arabia: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 8.             Saudi Arabia: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 9.             Saudi Arabia: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 10.          South Africa: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 11.          South Africa: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 12.          South Africa: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 13.          Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 14.          Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 15.          Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 16.          Organic Developments in the Carbapenem-based Antibiotics Market

Table 17.          Inorganic Developments in the Carbapenem-based Antibiotics Market

Table 18.          Glossary of Terms, Carbapenem-based Antibiotics Market

 


LIST OF FIGURES

Figure 1.           Carbapenem-based Antibiotics Market Segmentation

Figure 2.           Carbapenem-based Antibiotics Segmentation, By Country

Figure 3.           Middle East and Africa Carbapenem-based Antibiotics Market Overview

Figure 4.           The Others Segment Held Largest Share of Type Segment in Carbapenem-based Antibiotics Market

Figure 5.           Middle East and Africa Carbapenem-based Antibiotics Market- Leading Country Markets (US$ Million)

Figure 6.           Middle East and Africa PEST Analysis

Figure 7.           Carbapenem-based Antibiotics Market Impact Analysis of Driver and Restraints

Figure 8.           Middle East and Africa Carbapenem-based Antibiotics Market – Revenue Forecast and Analysis – 2021- 2028

Figure 9.           Carbapenem-based Antibiotics Market Revenue Share, by Type (2021 and 2028)

Figure 10.        Meropenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        Doripenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Imipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Tebipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Carbapenem-based Antibiotics Market, by Indication, 2021 and 2028 (%)

Figure 16.        Bacterial Meningitis: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Acute Pelvic Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Respiratory Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Intra-abdominal Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Urinary Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Carbapenem-based Antibiotics Market, by Distribution Channel, 2021 and 2028 (%)

Figure 23.        Retail Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Online Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Hospital Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Middle East and Africa: Carbapenem-based Antibiotics Market, by Key Country – Revenue (2021) (US$ ‘Million)

Figure 27.        Middle East and Africa: Carbapenem-based Antibiotics Market Revenue and Forecast to 2028 (US$ ‘Million)

Figure 28.        Middle East and Africa: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)

Figure 29.        UAE: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 30.        Saudi Arabia: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 31.        South Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 32.        Rest of Middle East and Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

The List of Companies - Middle East and Africa Carbapenem-Based Antibiotics Market

  1. ACS Dobfar S.p.A
  2. Aurobindo Pharma Ltd
  3. DAEWOONG PHARMACEUTICAL CO., LTD
  4. Gland Pharma Limited
  5. Merck & Co., Inc.
  6. Sumitomo Dainippon Pharma Co., Ltd.
  7. Savior Lifetec
  8. Pfizer Inc.
  9. Spero Therapeutics